CLINICAL TRIALS PROFILE FOR ANGIOTENSIN LL ACETATE
✉ Email this page to a colleague
All Clinical Trials for ANGIOTENSIN LL ACETATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00239096 ↗ | Prevention of Decompensation in Liver Cirrhosis | Unknown status | Else Poulsen Mindelegat | Phase 4 | 2005-09-01 | The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic. |
| NCT00239096 ↗ | Prevention of Decompensation in Liver Cirrhosis | Unknown status | Lundbeck Foundation | Phase 4 | 2005-09-01 | The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic. |
| NCT00239096 ↗ | Prevention of Decompensation in Liver Cirrhosis | Unknown status | University of Southern Denmark | Phase 4 | 2005-09-01 | The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic. |
| NCT00239096 ↗ | Prevention of Decompensation in Liver Cirrhosis | Unknown status | Odense University Hospital | Phase 4 | 2005-09-01 | The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ANGIOTENSIN LL ACETATE
Condition Name
Clinical Trial Locations for ANGIOTENSIN LL ACETATE
Trials by Country
Clinical Trial Progress for ANGIOTENSIN LL ACETATE
Clinical Trial Phase
Clinical Trial Sponsors for ANGIOTENSIN LL ACETATE
Sponsor Name
